Clinical Trial Update: Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing topical imiquimod with surgical LEEP for cervical intraepithelial neoplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Imiquimod (imiquimod)

Snippet

Sponsor: United States Naval Medical Center, San Diego | Conditions: Cervical Intraepithelial Neoplasia | Phase 2, Phase 3 | Status: COMPLETED